Latest Biotech Startup Funding Rounds

Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.

This page showsSector: Biotech
Rounds
477
Jan 1 – Oct 25, 2026
Disclosed funding
$20.2B
403 disclosed amounts
Median round
$20M
Of disclosed amounts
477 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
ImpriMedHealthtech · South KoreaCompany profile

A precision-oncology service that tests live cancer cells against drugs and uses clinical data to predict which treatments may work best for each patient.

A precision-oncology service that tests live cancer cells against drugs and uses clinical data to predict which treatments may work best for each patient.

$10MSeries A2 bridgeUndisclosedBiotech, HealthtechSouth KoreaInvestors
Axio BioPharmaEnterprise software · United StatesCompany profile

A data platform that connects pharmaceutical manufacturers and their production partners while each organization keeps control of its own systems and records.

A data platform that connects pharmaceutical manufacturers and their production partners while each organization keeps control of its own systems and records.

$2.4MPre-seedBiotech, Enterprise softwareUnited StatesInvestors
Novadip BiosciencesBiotech · BelgiumCompany profile

A clinical-stage biotechnology company developing regenerative cell therapies and grafts to repair bone and other damaged tissues, including a pivotal-stage treatment for a rare pediatric bone disorder.

A clinical-stage biotechnology company developing regenerative cell therapies and grafts to repair bone and other damaged tissues, including a pivotal-stage treatment for a rare pediatric bone disorder.

€10.4MConvertible financingUndisclosedBiotechBelgiumInvestors
RobigoAgritech · United StatesCompany profile

Robigo engineers biological crop-protection solutions that use targeted microbes to control plant pathogens while preserving beneficial organisms.

Robigo engineers biological crop-protection solutions that use targeted microbes to control plant pathogens while preserving beneficial organisms.

UndisclosedSeries ABiotech, AgritechUnited StatesInvestors
Tempo TherapeuticsBiotech · United StatesCompany profile

A regenerative-medicine company developing injectable microporous scaffolds that help the body rebuild tissue at damaged sites.

A regenerative-medicine company developing injectable microporous scaffolds that help the body rebuild tissue at damaged sites.

$14.5MFundingUndisclosedBiotechUnited StatesInvestors
Eterna RegenerativesHealthtech · United KingdomCompany profile

Eterna Regeneratives develops keratin-based biomaterials that guide mineral growth to repair enamel and, in a separate application, support bone regeneration. Its research-led platform is moving from proof of concept toward dental and orthopaedic products.

Eterna Regeneratives develops keratin-based biomaterials that guide mineral growth to repair enamel and, in a separate application, support bone regeneration. Its research-led platform is moving from proof of concept toward dental and orthopaedic products.

$4MSeedBiotech, HealthtechUnited KingdomInvestors
PolyphronBiotech · United StatesCompany profile

An AI-guided tissue-engineering platform that grows human micro-tissues and models their responses to support drug research and development.

An AI-guided tissue-engineering platform that grows human micro-tissues and models their responses to support drug research and development.

$20MSeedBiotechUnited StatesInvestors
Big Picture BioBiotech · United KingdomCompany profile

Big Picture Bio builds a cancer research model that predicts which drug combinations may work together, helping biopharma teams prioritize therapies and experiments.

Big Picture Bio builds a cancer research model that predicts which drug combinations may work together, helping biopharma teams prioritize therapies and experiments.

£2.2MPre-seed and Innovate UK grant packagePre-seedBiotechUnited KingdomInvestors
Anew LabsBiotech · ChinaCompany profile

An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.

An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.

$290MFundingUndisclosedBiotechChinaInvestors
ChemifyIndustrial tech · United KingdomCompany profile

Chemify turns digital chemistry programs into real molecules through software, robotics and AI. Pharmaceutical, biotechnology and materials R&D teams can use its Chemputation platform and automated Chemifarm to design, synthesize and test compounds.

Chemify turns digital chemistry programs into real molecules through software, robotics and AI. Pharmaceutical, biotechnology and materials R&D teams can use its Chemputation platform and automated Chemifarm to design, synthesize and test compounds.

£22M£22 million grant packageUndisclosedBiotech, Industrial techUnited KingdomInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · From Jan 1, 2026

  1. 1
    RA Capital Management

    Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology

    23rounds
    3led
  2. 2
    Janus Henderson Investors

    Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics

    15rounds
    1led
  3. 3
    Eli Lilly and Company

    BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences

    15rounds
    0led
  4. 4
    ARCH Venture Partners

    Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences

    14rounds
    0led
  5. 5
    OrbiMed

    Star Therapeutics, Leal Therapeutics, Accro Bioscience

    11rounds
    1led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic